Type 1 diabetes: treatment [sounds like]
409 results
1 - 100
Type 1 diabetes: treatment - Essentials
- Aims of treatment
- References
- Insulin products in the treatment of type 1 diabetes
- Principles of insulin administration
- Continuous glucose monitoring and self-monitoring of blood glucose
- Insulin treatment and diet
- Physical exercise and insulin treatment
- Hypoglycaemia
- Hyperglycaemia
- Guidance and support of self-care
- Regular check-ups of patients with diabetes
Hormone replacement therapy for women with type 1 diabetes mellitus: Cochrane systematic review- Follow-up of type 1 diabetes
- Enhanced glucose control for preventing and treating diabetic neuropathy
- Comprehensive treatment and follow-up of type 2 diabetes
- Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
SGLT-2 inhibitors or GLP-1 receptor agonists reduce cardiovascular outcomes in patients with type 2 diabetes- Individualizing target goals and treatment in patients with type 2 diabetes
- Dipeptidyl‐peptidase (DPP)‐4 inhibitors and glucagon‐like peptide (GLP)‐1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus
- Guidelines for when to consider mortality-reducing treatments for patients with type 2 diabetes
- Hydrolyzed infant formula does not reduce the risk of type 1 diabetes
- Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents
- In older adults with type 2 diabetes, GLP-1 agonists decrease major adverse cardiovascular events; SGLT2 inhibitors prevent heart failure hospitalizations
- Bariatric surgery is associated with fewer major adverse cardiac events than GLP-1 agonists in obese adults with type 2 diabetes
- Glucagon-like peptide analogues (GLP-1 analogues) for type 2 diabetes
- Intermediate acting versus long acting insulin for type 1 diabetes mellitus
- Effect of the treatment of type 2 diabetes mellitus on the development of cognitive impairment and dementia
- Treating prediabetes with tirzepatide helps obese patients lose weight and decreases likelihood of type 2 diabetes mellitus (SURMOUNT-1)
- Routine hospital admission versus out‐patient or home care in children at diagnosis of type 1 diabetes mellitus
- Association of systolic blood pressure and complications of type 2 diabetes
- SGLT-2 inhibitors in type 2 diabetes
- Older treatments for type 2 diabetes do not affect patient-oriented outcomes
- Alpha‐lipoic acid for diabetic peripheral neuropathy
- Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus
- Newly diagnosed type 1 diabetes in a child
- Diabetic kidney disease (diabetic nephropathy)
- Different insulin types and regimens for pregnant women with pre‐existing diabetes
- Insulin added on metformin in type 2 diabetes
- Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus: Cochrane systematic review
- Gestational diabetes mellitus (GDM)
- Dietary advice and exercise for type 2 diabetes mellitus
- Group based training for self-management strategies in people with type 2 diabetes mellitus
- Hyperbaric O2 therapy may improve diabetic foot ulcers
- Blood pressure control for diabetic retinopathy
- Glucagon‐like peptide 1 (GLP‐1) receptor agonists for people with chronic kidney disease and diabetes
- Interventions for latent autoimmune diabetes (LADA) in adults: Cochrane systematic review
- Glucagon-like peptide analogues for type 2 diabetes mellitus: Cochrane systematic review
- Continuous subcutaneous insulin infusion for type 1 diabetes
- Exercise for pregnant women with pre‐existing diabetes for improving maternal and fetal outcomes
- Oral antidiabetic drugs and GLP-1 analogues
- SGLT-2 inhibitors and GLP-1 agonists for diabetes and chronic kidney disease
- Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia
- Mediterranean diet delays treatment of type 2 diabetes
- USPSTF 2021 recommends screening for gestational diabetes in asymptomatic pregnant persons at 24+ weeks (B recommendation)
- Linagliptin and glimepiride equally effective for adults with type 2 diabetes
- Treatments for gestational diabetes
- Risk test for type 2 diabetes
- A child or adolescent with type 1 diabetes in primary health care
- Type 1 diabetes in fair to good control not associated with reduced school performance in children
- Short‐acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus
- Fenofibrate for diabetic retinopathy
- Linagliptin and glimepiride equally effective for adults with type 2 diabetes: POEM amended to include Canadian pricing
- Psychological interventions for diabetes‐related distress in adults with type 2 diabetes mellitus
- Different lasers and techniques for proliferative diabetic retinopathy: Cochrane systematic review
- Insulin therapy in type 2 diabetes
- Newly diagnosed type 2 diabetes
- Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance
- GLP-1 agonists + basal insulin better than glycemic control in T2DM
- Sodium‐glucose co‐transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes
- Cinnamon for diabetes mellitus